This article is more than 5 years old. Information may no longer be current.

Ophthotech announces strategic review plan

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ophthotech Corp. announced it has initiated a plan to review its strategic alternatives to maximize shareholder value.

The principal focus of the plan is to actively explore obtaining rights to additional products, product candidates and technologies to treat ophthalmic diseases.

The company also announced Glenn P. Sblendorio will assume the role of president while continuing to serve as chief financial officer. Sblendorio previously served as the company’s executive vice president, chief financial officer and chief operating officer.

Lastly, the company announced the promotion of Keith Westby to senior vice president and chief operating officer.